Metabolism includes blood circulation, breathing, digestion of food, and contraction of muscles, among others. Metabolic testing helps to measure the wellness and health of an individual by determining and diagnosing diseases, which include diabetes and cardiovascular diseases such as hypertension, abdominal obesity, glucose intolerance, and dyslipidemia.
In 2016, Centers for Disease Control and Prevention (CDC) and World Health Organization (WHO) launched a collaborative initiative called “Global Hearts” that consists of various programs to deal with metabolic diseases, cancer, and cardiovascular diseases. This program included controlling unhealthy diets in healthy individuals and offered a technical package for cardiovascular diseases. This initiative was at aimed fighting with non-communicable diseases and made them visible to take effective actions.
Increasing health care expenditure, growing prevalence of lifestyle associated diseases such as diabetes and obesity, rising health care awareness, and technological advancements are projected to facilitate the growth of the global metabolic testing market in the years to come.
Global metabolic testing market was valued at USD 484.3 million in 2018 and is expected to grow at a CAGR of 8.3% during the forecast period 2023–2031.
Get more information on this report Download Sample Report
The global metabolic testing market is segmented by technology, application, product, end user, and region.
Based on technology, the market is segmented into RMR analysis, VO2 max analysis, and body composition analysis. VO2 max analysis segment is expected to account for the largest share of the market owing to the capability of directly measuring oxygen consumption, which other tests try to estimate.
By application, the metabolic testing market is segmented into metabolic disorders, lifestyle diseases, human performance testing, critical care, dysmetabolic syndrome X, and others. Amongst application, lifestyle diseases segment is projected to dominate the market owing to the growing prevalence of lifestyle associated diseases across the globe. Metabolic disorders segment is expected to experience swift growth during the forecast period 2023–2031.
Based on product, the market is segregated into software, CPET systems, ECGs/EKGs attachable to CPET systems, metabolic carts, and body composition analyzers. Amongst product, CPET systems segment is expected to account for the largest share of the global metabolic testing market owing to the increasing demand due to the accuracy of the product. Metabolic carts segment is expected to grow significantly over the next few years. ECGs/EKGs attachable to CPET systems segment is expected to experience healthy growth during the forecast period 2023–2031.
By end user, the market is segmented into hospitals, laboratories, sports training centers, and others. Amongst the end users, the hospital's segment is expected to dominate the market owing to the increasing number of hospitals across the globe and improving the quality of the hospital services in developing regions.
By region, the global metabolic testing market is segmented into North America, Asia Pacific, Europe, the Middle East & Africa, and Latin America.
North America is expected to dominate the global metabolic testing market owing to increasing prevalence of cardiovascular diseases and metabolic disorders and the development of metabolic testing equipment and devices. In addition, well-established healthcare infrastructure in the North American region is anticipated to influence the market growth over the forecast period.
Asia Pacific is likely to emerge as the fastest growing region over the forecast period owing to the rising demand for qualitative medical solutions and improving the standard of living. Furthermore, rising research and development investments in the healthcare industry with the help of government initiatives and private organizations are expected to flourish the market growth. Moreover, the growing geriatric population and rising awareness are propelling the demand for metabolic testing in the region.
Regional Growth Insights Request Sample Pages
|Market Size||USD 484.3 million in 2018|
|Forecast Units||Value (USD Million)|
|Report Coverage||Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends|
|Segments Covered||by Technology (RMR Analysis, VO2 Max Analysis, Body Composition Analysis), Application, Product, End User|
|Geographies Covered||North America, Europe, Asia-Pacific, LAME and Rest of the World|
|Key Companies Profiled/Vendors||Parvo Medics (U.S.), AEI Technologies, Inc. (U.S.), Microlife Medical Home Solutions, Inc. (U.S.), KORR Medical Technologies , Inc. (U.S.), General Electric Company (U.S.), OSI Systems, Inc. (U.S.), Geratherm Medical AG (Germany), MGC Diagnostic Corporation (U.S.), CORTEX Biophysik GmbH (Germany), COSMED (Italy), and CareFusion Corporation (U.S.).|
|Key Market Opportunities||High Demand In Healthcare It Sector Is Pushing Metabolic Testing Market|
By End User
Why Buy This Report?
Our report covers the metabolic testing market insights, focusing on recent developments across different regions and development strategies of the companies. Following sections are specifically covered in the report.